Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...

Hormones and Bone Tissue

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Precision RNAi for Fibrodysplasia Ossificans Progressiva: a combinatorial, unimolecular, allele selective approach.

Research square·2026

Same author

Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model.

Nature communications·2026

Same author

"Anchoring-desolvating-shielding" spatially configurated Interface layer addressing the trade-off between Zn utilization, areal capacity and anti-calendar aging.

Journal of colloid and interface science·2026

Same author

Comparison of Bone Marrow Stimulation and Particulated Autologous Cartilage Transplantation for Osteochondral Lesions of the Talus With a 2-Year Follow-up.

Orthopaedic journal of sports medicine·2026

Same author

Control of lipid metabolism in chondrocytes is critical for skeletal growth.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Primary Modified Broström Procedure Shows Superior Outcome to Revision to Lateral Ankle Ligament Reconstruction in Patients With Chronic Lateral Ankle Instability at 5-Year Follow-Up.

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association·2026

Same journal

Dihydroartemisinin inhibits mutant KRAS to potentiate regorafenib plus anti-PD-1 in KRAS-mutant colorectal cancer liver metastases.

Cell death & disease·2026

Same journal

The alternative NF-κB RelB subunit is a novel critical sensor of lipid metabolism to promote tumor development.

Cell death & disease·2026

Same journal

Activation of KIT signaling promotes early tumorigenesis through the AP-1 pathway in APC/TP53 double-knockout human colon organoids.

Cell death & disease·2026

Same journal

Rethinking LPCAT3 roles in human disease: broadening perspectives beyond ferroptosis.

Cell death & disease·2026

Same journal

GDPPH1 induces cell cycle arrest by downregulation of CDK4/Cyclin D1 via the m<sup>6</sup>A-METTL14-YTHDF2 axis, attenuating glioblastoma progression.

Cell death & disease·2026

Same journal

Tumor-derived PCSK9-enriched exosomes reprogram adipocytes to drive metabolic dysregulation and immune evasion in triple-negative breast cancer.

Cell death & disease·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

USP24-dependent STAT2 stabilization mediates physiologic and pathologic bone formation.

Jung-Min Kim¹, Yeon-Suk Yang^2,3, Jun Xie^2,4,5

¹Department of Biology, College of Sciences, Kyung Hee University, Seoul, South Korea. jungminkim@khu.ac.kr.

Cell Death & Disease

|May 30, 2026

Summary

This summary is machine-generated.

The deubiquitinating enzyme USP24 regulates osteoblast development and heterotopic ossification (HO) by stabilizing STAT2. USP24-STAT2 signaling is crucial for bone formation and may be a therapeutic target for pathological bone conditions.

More Related Videos

Using Inducible Osteoblastic Lineage-Specific Stat3 Knockout Mice to Study Alveolar Bone Remodeling During Orthodontic Tooth Movement

Using Inducible Osteoblastic Lineage-Specific Stat3 Knockout Mice to Study Alveolar Bone Remodeling During Orthodontic Tooth Movement

Published on: July 21, 2023

Related Experiment Videos

Last Updated: Jun 1, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

Using Inducible Osteoblastic Lineage-Specific Stat3 Knockout Mice to Study Alveolar Bone Remodeling During Orthodontic Tooth Movement

Using Inducible Osteoblastic Lineage-Specific Stat3 Knockout Mice to Study Alveolar Bone Remodeling During Orthodontic Tooth Movement

Published on: July 21, 2023

Area of Science:

Biochemistry
Cell Biology
Skeletal Biology

Background:

Precise regulation of osteoblast development is critical for skeletal health, preventing conditions like low bone mass and heterotopic ossification (HO).
The deubiquitinating enzyme USP24's role in bone formation and pathological ossification is not well understood.

Purpose of the Study:

To investigate the role of USP24 in regulating osteoblast differentiation and ossification.
To explore the potential of USP24-STAT2 signaling as a therapeutic target for HO.

Main Methods:

Investigated USP24 expression in skeletal tissues and HO lesions.
Utilized USP24 deficiency models and recombinant adeno-associated virus (rAAV)-mediated gene silencing in a fibrodysplasia ossificans progressiva (FOP) mouse model.
Assessed osteoblast differentiation, STAT2 stabilization, and bone morphogenetic protein (BMP) signaling pathways.

Main Results:

USP24 is highly expressed in skeletal tissues and promotes osteoblast development by stabilizing STAT2 via deubiquitination.
Loss of USP24 or STAT2 impairs osteoblast differentiation and bone formation.
USP24 and STAT2 are upregulated in HO lesions, and USP24 inhibition reduces HO pathogenesis in an FOP mouse model.
USP24 deficiency attenuates activin A-induced BMP signaling and osteogenesis.

Conclusions:

USP24 is a key regulator of both physiological osteoblast differentiation and pathological heterotopic ossification.
The USP24-STAT2 signaling axis plays a critical role in controlling bone formation.
Targeting USP24-STAT2 signaling presents a potential therapeutic strategy for treating pathological bone formation, including HO.